Kaijie Pan
Overview
Explore the profile of Kaijie Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Du Q, Liu Z, Wang H, Wang Y, Liu L, Wen X, et al.
Front Pediatr
. 2024 Sep;
12:1382165.
PMID: 39318618
Objectives: To describe the carriage rate, serotype distribution, and antimicrobial susceptibility patterns of () nasopharyngeal (NP) isolates among healthy children aged 30 days to <60 months in the cities of...
2.
Duncan P, Mears R, Begier E, Rouhbakhsh Halvaei S, Southern J, Porter S, et al.
BJGP Open
. 2024 Sep;
8(4).
PMID: 39251234
Background: The true burden of acute lower respiratory tract disease (aLRTD; includes acute lower respiratory tract infection [aLRTI] and presumed non-infective exacerbations of chronic lung disease and heart failure) among...
3.
Li L, Pan K, Li J, Jiang M, Gao Y, Yang H, et al.
Sci Rep
. 2024 Aug;
14(1):19072.
PMID: 39154124
Social isolation was associated with emotional problems (depression and anxiety) among older adults, however, little is known in China. Thus, we conducted a cross-sectional study including 6,664 ≥ 65 years...
4.
Ankert J, Hagel S, Schwarz C, Pan K, Wang L, von Eiff C, et al.
ERJ Open Res
. 2023 Jun;
9(3).
PMID: 37260459
https://bit.ly/3JMlwFt.
5.
Hansen K, Runow E, Torisson G, Theilacker C, Palmborg A, Pan K, et al.
Front Public Health
. 2023 Mar;
11:1086648.
PMID: 36875379
Objectives: In Sweden, pneumococcal serotype distribution in adults with community-acquired pneumonia (CAP) and potential coverage of currently licensed pneumococcal conjugate vaccines (PCVs) is unknown. Methods: During 2016-2018, patients aged ≥18...
6.
Stark J, Li X, Zhang J, Burn L, Valluri S, Liang J, et al.
Emerg Infect Dis
. 2022 Nov;
28(12):2389-2397.
PMID: 36417925
Since its initial identification in 1986, Lyme disease has been clinically diagnosed in 29 provinces in China; however, national incidence data are lacking. To summarize Lyme disease seropositivity data among...
7.
Liatsikos K, Hyder-Wright A, Pojar S, Chen T, Wang D, Davies K, et al.
BMJ Open
. 2022 Jul;
12(7):e062109.
PMID: 35798520
Introduction: Despite widely available vaccinations (SPN) remains a major cause of morbidity and mortality worldwide, causing community-acquired pneumonia, meningitis, otitis media, sinusitis and bacteraemia. Here, we summarise an ethically approved...
8.
Singer S, Angulo F, Swerdlow D, McLaughlin J, Hazan I, Ginish N, et al.
EClinicalMedicine
. 2021 Dec;
42:101190.
PMID: 34870134
Background: SARS-CoV-2 variant Beta (B.1.351) was designated as a Variant of Concern (VoC) after becoming the dominant strain in South Africa and spreading internationally. BNT162b2 showed lower levels of neutralizing...
9.
Haas E, McLaughlin J, Khan F, Angulo F, Anis E, Lipsitch M, et al.
Lancet Infect Dis
. 2021 Sep;
22(3):357-366.
PMID: 34562375
Background: On Dec 20, 2020, Israel initiated a nationwide COVID-19 vaccination campaign for people aged 16 years and older and exclusively used the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine (tozinameran). We...
10.
Haas E, Angulo F, McLaughlin J, Anis E, Singer S, Khan F, et al.
Lancet
. 2021 May;
397(10287):1819-1829.
PMID: 33964222
Background: Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Health (MoH) launched a campaign to immunise the...